Overview

A Randomized Controlled Trial of Doxazosin for Nightmares, Sleep Disturbance, and Non-Nightmare Clinical Symptoms in PTSD

Status:
Unknown status

Trial end date:
2021-06-01

Target enrollment:

Participant gender:

Summary

This randomized, double-blind, placebo-controlled trial of doxazosin will assess doxazosin's effectiveness for PTSD nightmares, subjective sleep quality, and non-nightmare PTSD symptoms in adult men and women veterans with full and partial-syndromal PTSD.

Phase:

Phase 2

Details

Lead Sponsor:

San Francisco Veterans Affairs Medical Center

Collaborators:

Northern California Institute of Research and Education
United States Department of Defense

Treatments:

Doxazosin